Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Clinical trial NCT01570790 · COMPLETED

Trial details

NCT number: NCT01570790
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Combretastatin A4 Phosphate Age-related Macular Degeneration AMD CNV Choroidal Neovascularization

Start date: 2003-05-01
Primary completion: 2005-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.